Nutrien (NYSE:NTR) Upgraded at Piper Sandler

Piper Sandler upgraded shares of Nutrien (NYSE:NTRFree Report) from an underweight rating to an overweight rating in a report released on Monday morning, Marketbeat Ratings reports. They currently have $58.00 price objective on the stock, up from their prior price objective of $50.00.

Several other brokerages have also recently weighed in on NTR. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $60.00 price target on shares of Nutrien in a research note on Friday, September 20th. UBS Group downgraded shares of Nutrien from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $66.00 to $51.00 in a research report on Thursday, October 10th. CIBC reissued an “outperformer” rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Wells Fargo & Company lowered shares of Nutrien from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $62.00 to $50.00 in a research note on Tuesday, September 24th. Finally, TD Securities decreased their target price on shares of Nutrien from $63.00 to $61.00 and set a “buy” rating for the company in a research note on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Nutrien currently has a consensus rating of “Moderate Buy” and an average target price of $59.21.

Read Our Latest Stock Report on Nutrien

Nutrien Trading Up 0.8 %

NYSE:NTR opened at $52.08 on Monday. The company has a 50-day moving average price of $46.90 and a 200-day moving average price of $47.85. The stock has a market cap of $25.64 billion, a price-to-earnings ratio of 34.95, a P/E/G ratio of 1.11 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien has a 12 month low of $43.69 and a 12 month high of $60.87.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). The company had revenue of $5.35 billion during the quarter, compared to analysts’ expectations of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business’s quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter last year, the business earned $0.35 earnings per share. Equities analysts predict that Nutrien will post 3.5 EPS for the current year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st will be paid a $0.939 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.76 annualized dividend and a dividend yield of 7.21%. This is a boost from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is currently 144.97%.

Institutional Investors Weigh In On Nutrien

Institutional investors have recently modified their holdings of the business. Goodman Financial Corp raised its position in Nutrien by 4.6% in the 3rd quarter. Goodman Financial Corp now owns 253,860 shares of the company’s stock worth $12,201,000 after buying an additional 11,058 shares during the last quarter. CORDA Investment Management LLC. grew its stake in shares of Nutrien by 7.0% in the third quarter. CORDA Investment Management LLC. now owns 494,745 shares of the company’s stock worth $23,777,000 after acquiring an additional 32,541 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Nutrien by 10.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,742,351 shares of the company’s stock valued at $83,812,000 after purchasing an additional 157,932 shares during the last quarter. Cardinal Capital Management Inc. lifted its position in Nutrien by 4.3% during the third quarter. Cardinal Capital Management Inc. now owns 564,078 shares of the company’s stock valued at $27,139,000 after purchasing an additional 23,117 shares during the period. Finally, Stephens Inc. AR boosted its holdings in Nutrien by 335.0% in the third quarter. Stephens Inc. AR now owns 70,301 shares of the company’s stock worth $3,379,000 after purchasing an additional 54,138 shares during the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.